Carcinoma of the pancreas with portal vein involvement--our experience with a modified technique of resection
- PMID: 16201124
Carcinoma of the pancreas with portal vein involvement--our experience with a modified technique of resection
Abstract
Background/aims: Up to 40% of the patients with pancreatic carcinoma are not fit for curative resection due to the locally advanced nature of the disease in the form of vascular involvement. In recent years a more aggressive approach of vascular resection with pancreaticoduodenectomy (PD) has resulted in the increase in resectability rate and survival in this group of patients. The most important determinant of survival in these patients is negative resection margins. The aim of the present study is to present our experience of vascular resection using a modified technique, in patients with pancreatic cancer.
Methodology: This is a retrospective study of 48 patients who underwent portal vein/superior mesenteric vein (PV/SMV) resection along with PD using the modified technique of resection, during 1982-2004. The principle modification is the initial extensive retroperitoneal dissection for the assessment of the extent of tumor involvement of the superior mesenteric vessels and division of retroperitoneal margin before the division of the pancreas. All patients also underwent extended lymphadenectomy.
Results: The subtotal PD was done in 26 and total PD in 22 patients, with resection of the PV/SMV in all of them. The end-to-end anastomosis was possible after adequate mobilization of the PV and SMV in 40 patients. In 4 patients reconstruction was able to be done with the use of a graft. The portal vein occlusion time was 8-15 minutes. Histopathological examination showed negative margins in all the resected specimens. Postoperative complications occurred in 16.66% with reoperation rate of 8.33%, and mortality of 6.25%. After a mean follow-up of 110 months, mean survival was 40 months with the range of 18-250 months. The five-year and 10-year survival was 18% and 10% respectively. The venous patency rate was 100% at three years.
Conclusions: In conclusion, PD with en bloc resection of the PV/SMV confluence can safely be done with morbidity and mortality similar to that of standard PD. The survival advantage is directly related to the attainment of negative resection margins. The modified technique is a useful way of doing vascular resection with the least amount of bowel congestion and securing negative resection margins.
Similar articles
-
Prosthetic graft reconstruction after portal vein resection in pancreaticoduodenectomy: a multicenter analysis.J Am Coll Surg. 2010 Sep;211(3):316-24. doi: 10.1016/j.jamcollsurg.2010.04.005. Epub 2010 Jun 8. J Am Coll Surg. 2010. PMID: 20800187
-
Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head.Br J Surg. 1998 May;85(5):611-7. doi: 10.1046/j.1365-2168.1998.00641.x. Br J Surg. 1998. PMID: 9635805
-
Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy.Surgery. 2001 Feb;129(2):158-63. doi: 10.1067/msy.2001.110221. Surgery. 2001. PMID: 11174708 Clinical Trial.
-
Extended resection for pancreatic adenocarcinoma.Oncologist. 2007 Jun;12(6):654-63. doi: 10.1634/theoncologist.12-6-654. Oncologist. 2007. PMID: 17602057 Review.
-
Pancreatectomy combined with superior mesenteric-portal vein resection: report of 32 cases.Hepatobiliary Pancreat Dis Int. 2005 Feb;4(1):130-4. Hepatobiliary Pancreat Dis Int. 2005. PMID: 15730937 Review.
Cited by
-
Comparison between long and short-term venous patencies after pancreatoduodenectomy or total pancreatectomy with portal/superior mesenteric vein resection stratified by reconstruction type.PLoS One. 2020 Nov 5;15(11):e0240737. doi: 10.1371/journal.pone.0240737. eCollection 2020. PLoS One. 2020. PMID: 33151977 Free PMC article.
-
Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation.Cancer. 2012 Aug 1;118(15):3801-11. doi: 10.1002/cncr.26717. Epub 2011 Dec 16. Cancer. 2012. PMID: 22180096 Free PMC article.
-
Results of vascular resections during pancreatectomy from two European centres: an analysis of survival and disease-free survival explicative factors.HPB (Oxford). 2006;8(6):465-73. doi: 10.1080/13651820600839944. HPB (Oxford). 2006. PMID: 18333103 Free PMC article.
-
Vein involvement during pancreaticoduodenectomy: is there a need for redefinition of "borderline resectable disease"?J Gastrointest Surg. 2013 Jul;17(7):1209-17; discussion 1217. doi: 10.1007/s11605-013-2178-5. Epub 2013 Apr 26. J Gastrointest Surg. 2013. PMID: 23620151
-
Combined pancreaticoduodenectomy and extended right hemicolectomy: outcomes and indications.HPB (Oxford). 2009 Nov;11(7):559-64. doi: 10.1111/j.1477-2574.2009.00087.x. HPB (Oxford). 2009. PMID: 20495707 Free PMC article.
MeSH terms
LinkOut - more resources
Medical
Research Materials